GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » COGS-to-Revenue

Sun Pharma Advanced Research Co (NSE:SPARC) COGS-to-Revenue : 0.63 (As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is Sun Pharma Advanced Research Co COGS-to-Revenue?

Sun Pharma Advanced Research Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ₹171.8 Mil. Its Revenue for the three months ended in Mar. 2025 was ₹271.9 Mil.

Sun Pharma Advanced Research Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.63.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sun Pharma Advanced Research Co's Gross Margin % for the three months ended in Mar. 2025 was 36.82%.

Sun Pharma Advanced Research Co COGS-to-Revenue Historical Data

The historical data trend for Sun Pharma Advanced Research Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sun Pharma Advanced Research Co COGS-to-Revenue Chart

Sun Pharma Advanced Research Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.96 0.74 1.71 1.46

Sun Pharma Advanced Research Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.81 1.37 2.63 2.04 0.63

Sun Pharma Advanced Research Co COGS-to-Revenue Calculation

Sun Pharma Advanced Research Co's COGS to Revenue for the fiscal year that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1044.5 / 717.7
=1.46

Sun Pharma Advanced Research Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=171.8 / 271.9
=0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharma Advanced Research Co  (NSE:SPARC) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sun Pharma Advanced Research Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 171.8 / 271.9
=36.82 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sun Pharma Advanced Research Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sun Pharma Advanced Research Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sun Pharma Advanced Research Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sun Pharma Advanced Research Co Ltd (NSE:SPARC) » Definitions » COGS-to-Revenue
Comparable Companies
NSE:INNOVACAP BOM:524735 BOM:530239 BOM:506690 BOM:512529 BOM:524348 NSE:STAR BOM:524372 BOM:509079 BOM:500288 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
532872:India
Address
Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Website
https://www.sparc.life
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in othe4r countries.

Sun Pharma Advanced Research Co Headlines

No Headlines